Ambrx
@ambrxbio
Ambrx (Nasdaq: $AMAM) is developing a pipeline of Engineered Precision Biologics as treatments for cancer indications with a high unmet medical need.
ID: 1621573758963048451
03-02-2023 18:18:28
96 Tweet
1,1K Followers
29 Following
Thank you to all who attended Ambrx's KOL event discussing the ARX517 data presented at the 2023 European Society for Medical Oncology Congress meeting. A webcast replay of the event is available here: bit.ly/475J7dj $AMAM #ESMO23 ESMO - Eur. Oncology #ProstateCancer
